BIIB logo

Biogen (BIIB)

Profile

Full Name

Biogen Inc.

Ticker Symbol

BIIB

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

September 17, 1991

Indexes

S&P 500,NASDAQ 100

Website

http://www.biogen.com

Employees

7605

Key Details

Price

$124.76(-1.79%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$9.68B(-1.62% YoY)

Annual EPS

$11.18(+40.28% YoY)

PE ratio

12.32

Next earnings date

Aug 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $124.76
    BIIB price is $124.76

    30-Day Relative Volume

    0.72
    BIIB 30-day relative volume is 0.72

    Price Performance

    Price Today change

    -1.79%
    BIIB price is down -1.79% today

    Price YTD change

    -18.41%
    BIIB price is down -18.41% since January 1st

    Price 1-year change

    -44.3%
    BIIB price is down -44.3% year-on-year

    Price 3-year change

    -40.98%
    BIIB price is down -40.98% over the past 3 years

    Price Range

    Price All-time high

    $480.18
    BIIB price is currently -74.02% below its historical high of $480.18

    Price 3-year low

    $110.04
    BIIB price is currently +13.38% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $18.28B
    BIIB market capitalization is $18.28 billion

    Market cap 3-year change

    -40.95%
    BIIB market capitalization is down -40.95% over the past 3 years

    Market cap All-time high

    $111.67B
    BIIB market capitalization is currently -83.63% below its historical high of $111.67 billion

    Market cap sector rank

    95.18%
    BIIB market capitalization is higher than 95.18% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.64%
    BIIB shares outstanding is up +0.64% year-on-year

    Shares Outstanding 3-Year Change

    +0.05%
    BIIB shares outstanding is up +0.05% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.59
    BIIB beta is 0.59

    200-day SMA

    $151.11
    BIIB price is currently -17.44% below its 200-day simple moving average

    50-day SMA

    $124.45
    BIIB price is currently +0.25% above its 50-day simple moving average

    RSI

    41.78
    BIIB 14-day relative strength index is 41.78

    Volume

    0.72
    BIIB 30-day relative volume is 0.72

    ATR

    $3.19
    BIIB average true range is $3.19

    10-day Historical Volatility

    22.31%
    BIIB 10-day historical volatility is 22.31%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $9.68B
    BIIB annual revenue is $9.68 billion

    Revenue Analysts estimate

    $9.26B
    BIIB annual revenue is currently +4.49% higher than the consensus analysts' forecast

    Revenue 1-year change

    -1.62%
    BIIB annual revenue is down -1.62% year-on-year

    Revenue Sector rank

    94.01%
    BIIB annual revenue is higher than 94.01% of companies in Healthcare sector

    EPS

    EPS

    $11.18
    BIIB annual earnings per share is $11.18

    EPS Analysts estimate

    $14.84
    BIIB annual earnings per share is currently -24.64% lower than the consensus analysts' forecast

    EPS 1-year change

    +40.28%
    BIIB annual earnings per share is up +40.28% year-on-year

    EPS Sector rank

    98.44%
    BIIB annual earnings per share is higher than 98.44% of companies in Healthcare sector

    Profit

    Gross profit

    $7.37B
    BIIB annual gross profit is $7.37 billion

    Gross margin

    76.12%
    BIIB annual gross profit margin is 76.12%

    Operating profit

    $2.22B
    BIIB annual operating income is $2.22 billion

    Operating margin

    22.93%
    BIIB annual operating profit margin is 22.93%

    Net income

    $1.63B
    BIIB annual net profit is $1.63 billion

    Net margin

    16.87%
    BIIB annual net profit margin is 16.87%

    Expenses

    Total expenses

    $7.46B
    BIIB annual total expenses is $7.46 billion

    Operating expenses

    $5.15B
    BIIB annual total operating expenses is $5.15 billion

    Cost of goods sold

    $2.31B
    BIIB annual cost of goods sold is $2.31 billion

    Selling, general & administrative expenses

    $2.40B
    BIIB annual SGA is $2.40 billion

    Depreciation and amortization

    $673.20M
    BIIB annual depreciation & amortization is $673.20 million

    Interest expense

    $250.30M
    BIIB annual interest expense is $250.30 million

    Income tax

    $273.80M
    BIIB annual income tax is $273.80 million

    EBIT & EBITDA

    EBIT

    $2.16B
    BIIB annual earnings before interest & taxes is $2.16 billion

    EBITDA

    $2.83B
    BIIB annual EBITDA is $2.83 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $28.05B
    BIIB annual total assets is $28.05 billion

    Non current assets

    $20.59B
    BIIB annual long term assets is $20.59 billion

    Current assets

    $7.46B
    BIIB annual total current assets is $7.46 billion

    Cash and cash equivalents

    $2.38B
    BIIB annual cash & cash equivalents is $2.38 billion

    Accounts receivable

    $1.87B
    BIIB annual accounts receivable is $1.87 billion

    Inventory

    $2.46B
    BIIB annual inventory is $2.46 billion

    Liabilities

    Total liabilities

    $11.33B
    BIIB annual total liabilities is $11.33 billion

    Long term liabilities

    $5.80B
    BIIB annual total long term liabilities is $5.80 billion

    Current liabilities

    $5.53B
    BIIB annual total current liabilities is $5.53 billion

    Accounts payable

    $424.20M
    BIIB annual accounts payable is $424.20 million

    Debt

    Total debt

    $6.63B
    BIIB annual total debt is $6.63 billion

    Total debt 1-year change

    -9.65%
    BIIB annual total debt is down -9.65% year-on-year

    Long term debt

    $4.88B
    BIIB annual long term debt is $4.88 billion

    Short term debt

    $1.75B
    BIIB annual short term debt is $1.75 billion

    Equity & Capital

    Shareholders equity

    $16.72B
    BIIB annual stockholders equity is $16.72 billion

    Book value

    $16.72B
    BIIB annual book value is $16.72 billion

    Retained earnings

    $19.26B
    BIIB annual retained earnings is $19.26 billion

    Working capital

    $1.93B
    BIIB annual working capital is $1.93 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $2.88B
    BIIB annual cash flow from operations is $2.88 billion

    Cash from operations 1-year change

    +85.85%
    BIIB annual cash flow from operations is up +85.85% year-on-year

    Cash from investing

    -$799.20M
    BIIB annual cash flow from investing activities is -$799.20 million

    Cash from investing 1-year change

    +80.51%
    BIIB annual cash flow from investing activities is up +80.51% year-on-year

    Cash from financing

    -$683.50M
    BIIB annual cash flow from financing activities is -$683.50 million

    Cash from financing 1-year change

    -557.8%
    BIIB annual cash flow from financing activities is down -557.8% year-on-year

    CAPEX

    CAPEX

    $359.80M
    BIIB annual capital expenditures is $359.80 million

    CAPEX 1-year change

    +15.54%
    BIIB annual capital expenditures is up +15.54% year-on-year

    Free Cash Flow

    Free cash flow

    $2.52B
    BIIB annual free cash flow is $2.52 billion

    Free cash flow 1-year change

    +103.57%
    BIIB annual free cash flow is up +103.57% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    76.12%
    BIIB annual gross profit margin is 76.12%

    Operating margin

    22.93%
    BIIB annual operating profit margin is 22.93%

    Net margin

    16.87%
    BIIB annual net profit margin is 16.87%

    ROA & ROE

    ROA

    5.95%
    BIIB annual return on assets is 5.95%

    ROE

    10.36%
    BIIB annual return on equity is 10.36%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    12.32
    BIIB price to earnings ratio is 12.32

    PE ratio Sector rank

    22.43%
    BIIB price to earnings ratio is higher than 22.43% of companies in Healthcare sector

    PB Ratio

    PB ratio

    1.08
    BIIB price to book ratio is 1.08

    PB ratio Sector rank

    43.17%
    BIIB price to book ratio is higher than 43.17% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.86
    BIIB price to sales ratio is 1.86

    PS ratio Sector rank

    39.31%
    BIIB price to sales ratio is higher than 39.31% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $22.30B
    BIIB enterprise value is $22.30 billion

    Enterprise value Sector rank

    94.98%
    BIIB enterprise value is higher than 94.98% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    8.25
    BIIB EV/EBITDA is 8.25

    EV/EBITDA Sector rank

    80.82%
    BIIB EV/EBITDA is higher than 80.82% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.35
    BIIB annual current ratio is 1.35

    Quick ratio

    0.90
    BIIB annual quick ratio is 0.90

    Leverage

    Debt to equity

    0.38
    BIIB annual debt to equity ratio is 0.38

    Interest coverage ratio

    8.61
    BIIB annual interest coverage ratio is 8.61

    Risk & Stability

    Piotroski F-Score

    5
    BIIB piotroski f-score is 5

    Altman Z-Score

    2.61
    BIIB altman z-score is 2.61

    Analyst ratings

    Recent major analysts updates

    May 7, 25 Mizuho
    Outperform
    May 5, 25 JP Morgan
    Neutral
    May 2, 25 RBC Capital
    Outperform
    May 2, 25 Needham
    Hold
    May 2, 25 HC Wainwright & Co.
    Buy
    May 2, 25 Canaccord Genuity
    Buy
    May 2, 25 Baird
    Outperform
    Apr 29, 25 Truist Securities
    Buy
    Apr 29, 25 Piper Sandler
    Neutral
    Apr 25, 25 Needham
    Hold

    Institutional Ownership

    Screeners with BIIB included

    Growing Shares Outstanding
    US stocks
    S&P 500 companies earnings calendar
    Stocks below SMA 200
    NASDAQ 100 companies
    Most recommended stocks
    NASDAQ Dividend Calendar
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    • What is the ticker symbol for Biogen?
    • Does Biogen pay dividends?
    • What sector is Biogen in?
    • What industry is Biogen in?
    • What country is Biogen based in?
    • When did Biogen go public?
    • Is Biogen in the S&P 500?
    • Is Biogen in the NASDAQ 100?
    • Is Biogen in the Dow Jones?
    • When was Biogen's last earnings report?
    • When does Biogen report earnings?
    • Should I buy Biogen stock now?

    What is the ticker symbol for Biogen?

    The ticker symbol for Biogen is NASDAQ:BIIB

    Does Biogen pay dividends?

    No, Biogen does not pay dividends

    What sector is Biogen in?

    Biogen is in the Healthcare sector

    What industry is Biogen in?

    Biogen is in the Drug Manufacturers - General industry

    What country is Biogen based in?

    Biogen is headquartered in United States

    When did Biogen go public?

    Biogen's initial public offering (IPO) was on September 17, 1991

    Is Biogen in the S&P 500?

    Yes, Biogen is included in the S&P 500 index

    Is Biogen in the NASDAQ 100?

    Yes, Biogen is included in the NASDAQ 100 index

    Is Biogen in the Dow Jones?

    No, Biogen is not included in the Dow Jones index

    When was Biogen's last earnings report?

    Biogen's most recent earnings report was on May 1, 2025

    When does Biogen report earnings?

    The next expected earnings date for Biogen is Aug 1, 2025

    Should I buy Biogen stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page